Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of a neural chronic
inflammation, called HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) …

Human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a rare inflammatory disease causing unremitting and progressive …

Around ten million people are infected with HTLV-1 worldwide, and 1–4% develop HTLV-1-
associated myelopathy/tropical spastic paraparesis (HAM/TSP), characterized by an …

Human T lymphotropic virus type‐1 (HTLV‐1) is a well‐known human oncovirus, associated
with two life‐threatening diseases, adult T cell leukaemia/lymphoma (ATL) and HTLV‐1 …

The human T-cell lymphotropic virus type 1 (HTLV-1) infects 5-10 million people worldwide
and causes fatal and disabling diseases in a significant proportion of them. A chronic …

Abstract Background HTLV-1-associated myelopathy (HAM/TSP) is a progressive
neurodegenerative inflammatory condition of HTLV-1 infection. Viral-host interactions are a …

Abstract HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic
neuroinflammatory disease related to human T lymphotropic virus type 1 (HTLV-1) infection …

Human T-lymphotropic virus 1, a member of the Retroviridae family, causes a neglected,
silent, persistent infection affecting circa 5 to 10 million people around the world, with …

HTLV-1, the first human oncogenic retrovirus, is a type C retrovirus that belongs to the
Deltaretrovirus genus. The HTLV-1 genome has 8.5 kbp length, and consists of major genes …

ABSTRACT Introduction Nearly 2–3% of those 10 to 20 million individuals infected with the
Human T-cell lymphotropic virus type-1 (HTLV-1); are predisposed to developing HTLV-1 …